RSV Vaccine Options for U.S. Seniors to Become Available
Pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) have each developed a vaccine to protect older adults from a virus known as RSV. People over 60 are at significant risk of serious complications if they contract RSV. Fortunately, with the recent FDA approval of Pfizer’s Abrysvo vaccine and GSK’s Arexvy vaccine, along with practical safety measures, seniors […]
RSV Vaccine Options for U.S. Seniors to Become Available Read More »